Skip to main content

Table 3 Logistic regression for the therapeutic indicator of cognition: ΔMMSE

From: Cilostazol as an add-on therapy for patients with Alzheimer’s disease in Taiwan: a case control study

 

odds ratio

95% CI

p-value

Age, years (mean ± SD)

0.96

0.82–1.13

0.645

Education, years (mean ± SD)

0.95

0.79–1.15

0.584

Gender, female (%)

2.23

0.34–16.02

0.401

1st CDR–SB

2.06

1.31–3.72

<0.001

1st MMSE

1.41

1.11–1.90

0.004

Cilostazol use

0.17

0.03–0.80

0.024

ApoE ε4(+), n (%)

0.30

0.04–1.90

0.3173

  1. Odds ratios are based on comparing odds of poor (ΔMMSE < 0) versus favorable (ΔMMSE ≥0) therapeutic indicators of cognition
  2. MMSE Mini-Mental Status Examination, CDR_SB Clinical Dementia Rating Sum of Boxes scale; ApoE apolipoprotein E, ΔMMSE: 2nd MMSE–1st MMSE
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us